Richard Rosen, MD, Receives Prestigious Award From the American Society of Retina Specialists (ASRS)
Distinguished Mount Sinai professor given top honor for his contributions to advancing vitreoretinal surgery, treatment, research, and patient care
The American Society of Retina Specialists is honoring Richard B. Rosen, MD, ScD (hon), FACS, FASRS, FARVO, CRA, the Belinda Bingham Pierce and Gerald G. Pierce Distinguished Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai, with the prestigious Founders Award for 2024. He received this award at the 42nd ASRS Annual Meeting in Stockholm, Sweden, during a special ceremony on Friday, July 19.
The ASRS Founders Award recognizes Dr. Rosen’s significant contributions to the advancement of vitreoretinal surgery, treatment, research, and patient care, and his dedication to the field of ophthalmology. He is the first ophthalmologist from Mount Sinai to receive this annual award.
“I am most grateful to the nominating committee and leadership of the ASRS for this honor. I have been a member of the society since completing my retina fellowship in 1991 under the preceptorship of Dr. Thomas Muldoon and Dr. Joseph Walsh at New York Eye and Ear Infirmary of Mount Sinai (NYEE). It’s particularly gratifying to me since Dr. Muldoon was the faculty advisor to the Founders, Jerry Bovino, Roy Levit, and AllenVerne, and encouraged them to create the Vitreous Society, which eventually grew into the ASRS. Their contribution of including the wider community of retinal specialists within our country and beyond has expanded access to education, the latest treatment techniques, and professional camaraderie, which has had immense benefits for our patients, our trainees, and our profession,” says Dr. Rosen.
Dr. Rosen also serves as the Surgeon-Director, Chief of Retina Services, Vice Chair of Research, and Director of Retina Fellowships at NYEE. There, he has created one of the most advanced ocular imaging centers in the United States. This center uses novel technologies to explore the vascular basis of retinal diseases such as diabetic retinopathy, macular degeneration, glaucoma, and retinal trauma, and to examine the retina at a cellular level, which can lead to earlier detection and treatment of a range of blinding eye conditions. Dr. Rosen helped develop the first combined en face optical coherence tomography (OCT)/confocal scanning laser ophthalmoscope instruments, which were the forerunners of today’s non-invasive OCT angiography systems. This fostered the translation of other novel imaging systems to the clinical setting. Dr. Rosen lectures worldwide and has published more than 200 articles in peer-reviewed journals on topics including new treatments for macular degeneration and diabetic retinopathy, along with innovations in diagnostic retinal imaging and vitreo-retinal surgical instrumentation.
At ASRS, Dr. Rosen’s Founders Lecture focused on using dynamic OCT angiography and quad-fusion adaptive optics to identify subclinical sickle cell activity, undetectable with traditional clinical examination, in order to appreciate earlier disease and subtle treatment effects as they appear in individual patients.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. The Health System includes approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses across seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, a school of nursing, and schools of medicine and graduate school of biomedical sciences.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York and recognized as one of the world’s top Smart Hospital by Newsweek. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools for National Institutes of Health (NIH) funding and No. 1 among freestanding medical schools, reflecting the strength of its scientific enterprise and leadership in biomedical research.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Instagram, LinkedIn, X, and YouTube. To listen to news and stories from Mount Sinai, visit the Mount Sinai Podcast Network.
Blinding Eye Disease Strongly Associated With Serious Forms of Cardiovascular Disease
Nov 17, 2022 View All Press Releases
High-Tech Imaging Offers New Way to Detect Signs of Early Glaucoma
Aug 02, 2022 View All Press Releases
Blinding Eye Disease Is Strongly Associated With Heart Disease and Stroke
Jul 12, 2022 View All Press Releases
Mount Sinai Recruits Internationally Recognized Ophthalmologists to Expand Leadership
Dec 17, 2018 View All Press Releases